Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome

Mult Scler. 2012 Aug;18(8):1152-8. doi: 10.1177/1352458511433919. Epub 2012 Jan 4.

Abstract

Background: Relapse is a characteristic clinical feature of multiple sclerosis (MS) and is commonly employed as a measure of efficacy following therapeutic intervention. However, less is known about the temporal evolution of subsequent disability or factors predicting recovery.

Objectives: The objective of this study was to assess the pattern of recovery following relapse and identify factors which predict recovery and residual disability following relapse.

Methods: A total of 226 relapses were studied prospectively in a cohort of 144 patients with standardised clinical assessments of physical disability including Expanded Disability Status Scale (EDSS), 10-m timed walk, 9-hole peg test and Multiple Sclerosis Impact Scale (MSIS-29) at 0, 2, 6 and 12 months. A total of 82 patients completed 12 months of follow up without further relapse.

Results: Thirty per cent of relapses were severe (change in EDSS >2.0) of which 11% failed to recover. All measures showed significant improvement at 2 months but additional improvement was also observed in 9-hole peg test and MSIS-29 up to 12 months following initial assessment. Mean time to second relapse was 382 days. The only predictor of relapse severity in the model tested was younger age; however, increasing age and initial relapse severity were also predictors of poor outcome.

Conclusions: This study shows that the majority of improvement in physical disability following relapse occurs by 2 months but that more subtle recovery can take place over 12 months in a small sub-group of patients. These data will aid in patient counselling and will also inform the timing of therapeutic intervention and physical support.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Analysis of Variance
  • Disability Evaluation*
  • Exercise Test
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Logistic Models
  • Male
  • Middle Aged
  • Motor Activity
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / physiopathology
  • Multiple Sclerosis / therapy*
  • Neuropsychological Tests
  • Odds Ratio
  • Predictive Value of Tests
  • Prospective Studies
  • Recovery of Function
  • Recurrence
  • Remission Induction
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome
  • Wales
  • Walking
  • Young Adult